Results 141 to 150 of about 4,245 (200)

New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation. [PDF]

open access: yesBMC Chem
Ayoup MS   +8 more
europepmc   +1 more source

1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry. [PDF]

open access: yesACS Med Chem Lett, 2021
Aprile S   +7 more
europepmc   +1 more source

Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease. [PDF]

open access: yesACS Med Chem Lett, 2021
Stott AJ   +22 more
europepmc   +1 more source

1,2,4-Oxadiazole Derivatives: Physicochemical Properties, Antileishmanial Potential, Docking and Molecular Dynamic Simulations of Leishmania infantum Target Proteins. [PDF]

open access: yesMolecules
Barbosa DCS   +9 more
europepmc   +1 more source

Discovery of FO-4-15, a novel 1,2,4-oxadiazole derivative, ameliorates cognitive impairments in 3×Tg mice by activating the mGluR1/CaMKIIα pathway. [PDF]

open access: yesActa Pharmacol Sin
Luo ZH   +15 more
europepmc   +1 more source

Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents. [PDF]

open access: yesRSC Med Chem
Ayoup MS   +8 more
europepmc   +1 more source

New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold. [PDF]

open access: yesACS Chem Neurosci
Dallanoce C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy